BIO · Bio-Rad Laboratories, Inc.
$327.02
-3.98 (-1.20%)
At close · Jul 29
Market Cap
$8.86B
Shares
26.76M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
$500,000,000
as of 2025-12-31
Remaining Authorization
$284,600,000
as of 2025-12-31
Program Utilization
43.1%
$215,400,000 used of $500,000,000
Cash spent on buybacks by quarter
Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-03-31 YTD | $47,800,000 | 10-Q, filed 2026-04-30 | ||
| 2025-12-31 | $295,500,000 | 10-K, filed 2026-02-13 | ||
| 2024-12-31 | $203,600,000 | 10-K, filed 2026-02-13 | ||
| 2023-12-31 | $428,700,000 | 10-K, filed 2026-02-13 | ||
| 2022-12-31 | $215,700,000 | 10-K, filed 2025-02-14 | ||
| 2021-12-31 | $49,998,000 | 10-K, filed 2024-02-16 | ||
| 2020-12-31 | $100,004,000 | 10-K, filed 2023-02-17 | ||
| 2019-12-31 | $28,000,000 | 10-K, filed 2022-02-11 | ||
| 2018-12-31 | $48,912,000 | 10-K, filed 2021-02-16 | ||
| 2017-12-31 | $2,920,000 | 10-K, filed 2020-03-02 | ||
| 2016-12-31 | $0 | 10-K, filed 2019-04-01 | ||
| 2015-12-31 | $0 | 10-K, filed 2018-04-16 | ||
| 2014-12-31 | $0 | 10-K, filed 2015-03-02 | ||
| 2013-12-31 | $0 | 10-K, filed 2015-03-02 | ||
| 2012-12-31 | $101,000 | 10-K, filed 2015-03-02 | ||
Key facts
CIK
12208
CUSIP
090572207
13F (30d)
121 filings
94 filers
Visit website
Investor relations